Across TCGA pan-cancer cohorts, RNU6-330P RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated RNU6-330P data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher RNU6-330P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-330P expression acts as an unfavorable survival marker, although some lineages such as LAML show a favorable association.

LUAD, KIRC, and LAML are the cancer types where RNU6-330P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	All	0.235	0.697	.010	36	view →
KIRC	DFS	Tertile	All	0.260	0.796	.012	18	view →
LAML	DFS	Tertile	All	1.000	0.354	.031	12	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: RNU6-330P tumor-vs-normal RNA expression · all RNU6-330P data types